• Subject: Re: IBM Spin Doctors on AS/400 Marketing
  • From: Neil Palmer <NPalmer@xxxxxxxxxxx>
  • Date: Wed, 22 Oct 1997 23:05:24 -0400
  • Organization: NxTrend Technology - Canada

Dave Mahadevan wrote:
> 
> Neil Palmer wrote:
> 
> > Al Barsa, Jr. wrote:
> > >
> > > At 08:57 PM 10/21/97 -0400, you wrote:
> > > >
> > > >Yes, they will see YOUR message and could still argue it's just a
> BP
> > > >bitching.  If they get a minor flood of mail from customers on
> this
> > > >list, they may form a different opinion.
> > > >
> > > I'm saving all the mail.
> > >
> > > Al
> >
> > Good enough.
> >
> > OK everyone - Al's going to save the mail on this issue (&
> presumably
> > forward it to the 'large flightless bird with long neck' department
> at
> > IBM), so vent your spleens on this issue !
> >
> >
> 
> Excepting mine because I asked for V3R2 :-)
> 


Hey Dave - you can have V3R2 for Xmas if you're good !
You won't get a V3R3 though !!

-- 
... Neil Palmer                                      AS/400~~~~~      
... NxTrend Technology -Canada       ____________          ___  ~     
... Thornhill, Ontario, Canada       |OOOOOOOOOO| ________  o|__||=   
... Phone: (905) 731-9079 x238       |__________|_|______|_|______)   
... url:http://www.NxTrend.com        oo      oo   oo  oo   OOOo=o\   
... mailto:NPalmer@NxTrend.com     ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
+---
| This is the Midrange System Mailing List!
| To submit a new message, send your mail to "MIDRANGE-L@midrange.com".
| To unsubscribe from this list send email to MAJORDOMO@midrange.com
|    and specify 'unsubscribe MIDRANGE-L' in the body of your message.
| Questions should be directed to the list owner/operator: david@midrange.com
+---


This thread ...

Replies:

Follow On AppleNews
Return to Archive home page | Return to MIDRANGE.COM home page

This mailing list archive is Copyright 1997-2019 by midrange.com and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available on our policy page. If you have questions about this, please contact [javascript protected email address].